Stay updated on Teclistamab vs PVd/Kd in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Teclistamab vs PVd/Kd in Multiple Myeloma Clinical Trial page.

Latest updates to the Teclistamab vs PVd/Kd in Multiple Myeloma Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedA new study-record version was added, documenting updates to the study status, conditions, arms and interventions, and contacts/locations, along with an IPD-sharing entry. The history now shows the latest version submitted on 2026-11-02 and posted on 2026-11-04.SummaryDifference0.5%

- Check15 days agoChange DetectedThe footer now identifies the website as revision v3.8.0 instead of v3.7.2.SummaryDifference0.1%

- Check22 days agoChange DetectedAn NIH banner announces a website transition and says some federal agencies are using “Super Intelligence” instead of “Artificial Intelligence” during the transition.SummaryDifference0.4%

- Check29 days agoChange DetectedThe site footer revision label changed from v3.7.1 to v3.7.2; the study record content remains unchanged.SummaryDifference0.1%

- Check36 days agoChange DetectedThe footer now displays ClinicalTrials.gov revision v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check57 days agoChange DetectedA new revision tag Revision: v3.7.0 was added to the study record history, and the previous Revision: v3.6.6 tag was removed, updating the page's revision history.SummaryDifference0.1%

Stay in the know with updates to Teclistamab vs PVd/Kd in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Teclistamab vs PVd/Kd in Multiple Myeloma Clinical Trial page.